Horan Securities’s GSK GSK Stock Holding History

Horan Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200	Closed	-$7.13K	–	317
2023 Q2	$7.13K	Hold	200	–	–	﹤0.01%	432
2023 Q1	$7.12K	Sell	200 -40	-17%	-$1.4K	﹤0.01%	428
2022 Q4	$8.43K	Hold	240	–	–	﹤0.01%	391
2022 Q3	$7K	Hold	240	–	–	﹤0.01%	380
2022 Q2	$12K	Buy	240 +40	+20%	+$2.21K	0.01%	300
2022 Q1	$11K	Hold	200	–	–	0.01%	312
2021 Q4	$11K	Buy	+200	New	+$10.4K	0.01%	310
2021 Q2	$10K	Hold	200	–	–	0.01%	302
2021 Q1	$9K	Hold	200	–	–	0.01%	285
2020 Q4	$9K	Buy	+200	New	+$9.19K	0.01%	270
2020 Q3	–	Sell	-132	Closed	-$7K	–	356
2020 Q2	$7K	Buy	+132	New	+$6.77K	0.01%	210

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Horan Securities's GSK Position: Q3 2023 in Review

Horan Securities sold out of GSK (GSK) in Q3 2023, closing a stake of 200 shares — an estimated $7.13K sold.

Horan Securities first reported a position in GSK in Q2 2020 and held it in 11 quarters. The position peaked at $12K in Q2 2022. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Horan Securities reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Horan Securities sold 200 GSK shares in Q3 2023, an estimated $7.13K.
Horan Securities first reported a position in GSK in Q2 2020 and held it in 11 quarters.
Horan Securities's GSK position peaked at $12K in Q2 2022.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.